PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
15-Feb-2024 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of The Children's Place, Inc. (PLCE) on Behalf of Investors Businesswire
15-Feb-2024 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of InMode Ltd. (INMD) on Behalf of Investors Businesswire
15-Feb-2024 Areteia Therapeutics gibt Ernennung von Daniel Becker, M.D., Ph.D. in Areteia Board of Directors bekannt Businesswire
15-Feb-2024 Global Actuators Strategic Industry Report 2024: Reach $108.7 Billion by 2030 - Smart Cities Emerge as Major Opportunity - ResearchAndMarkets.com Businesswire
15-Feb-2024 MedinCell to Present at the Evercore ISI 2024 Emerging Biotech Conference Businesswire
15-Feb-2024 Areteia Therapeutics annonce la nomination de Daniel Becker, M.D., Ph.D. au conseil d'administration Businesswire
15-Feb-2024 INMD INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that InMode Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! Businesswire
15-Feb-2024 INDM INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that InMode Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Businesswire
15-Feb-2024 eClinical Solutions Highlights Notable Year of Growth Supporting Biopharma's Complex Data Demands Businesswire
15-Feb-2024 Simulations Plus Extends Collaboration with Major Toxicology Research Agency Businesswire
15-Feb-2024 Lantern Pharma Advances Unique ADC (Antibody Drug Conjugate) Program Across Multiple Solid Tumor Cancers Businesswire
15-Feb-2024 Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief Scientific Officer Businesswire
15-Feb-2024 Kyriba’s Quarterly Currency Impact Report: Currency Impact Reported by North American and European Companies Totaled $30 Billion Businesswire
15-Feb-2024 Firefly Bio Debuts With $94 Million Series A Financing Businesswire
15-Feb-2024 Selkirk Pharma Announces New APS Qualified Facility with Advanced Fill/Finish Capacity in Spokane, WA Businesswire
15-Feb-2024 Areteia Therapeutics Announces Appointment of Daniel Becker, M.D., Ph.D. To Board of Directors Businesswire
15-Feb-2024 New Vitality Study Reveals: Employers Reduced Claims Costs by 4% and Achieved ROI of 180% from Claims Savings on Health and Wellbeing Program Businesswire
15-Feb-2024 SkyWater Signs Production Agreement with Nautilus Biotechnology to Fabricate Novel Biomedical Devices Businesswire
15-Feb-2024 Quince Therapeutics Appoints Former Reata Pharmaceuticals Chief R&D Officer Dr. Rajiv Patni to its Board of Directors Businesswire
15-Feb-2024 KalVista Pharmaceuticals Announces Pricing of a $160.1 Million Public Offering of Common Stock and Pre-Funded Warrants Businesswire